Global marketsUpdated November 4

CVS targets a pharmacy spin-off for the first half of 2028.

CVS had already confirmed its plan to separate the pharmacy business; Bloomberg now puts it in the first half of 2028. The retail operation would move into a new company, CVS Pharmacy, apart from Aetna’s insurance unit and Caremark’s prescription-benefits division. Bloomberg says both resulting companies would be publicly traded. The pharmacy business would emerge as a public company in its own right, not just a reshuffled part of CVS.

1 publisher1 report

Coverage started November 4